obesity drugs glp-1 news today Market Overview: GLP-1 Agonists and the Obesity Market As GLP-1 drugs continue to
Description
The next phase of GLP-1 expansion will be determined as much by manufacturing capacity and reimbursement dynamics as by clinical innovation
Case reports of retained solid gastric content in patients undergoing anesthesia
The findings were published Wednesday in the Journal of the American Medical Association
Details can be found at: 10.3389/fendo.2026.1810879
